Evaluating a social skills program for adolescents with rare neurodevelopmental disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the French version of the PEERS social skills training program aimed at adolescents and young adults with rare neurodevelopmental disorders. It focuses on improving social skills and relationships to reduce the risk of anxiety and depression during the transition to adulthood. Participants aged 12 to 30 years will be assessed for their social skills development while enrolled in the program. The study aims to understand the overall benefits of this intervention in a vulnerable population.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Aged between 12 and 30 years, included at the start of the social skills program.
* Patients with rare neurodevelopmental diseases
* Patients benefiting from the social skills program
* Appropriate level of verbal elaboration
* Patient with a family member or a friend also participating in the social skills program

Non-inclusion criteria :

* Opposition of the patient or, if a minor, of his/her parents to participation in the study
* Patient not psychiatrically stabilized: acute symptoms of anxiety, depression, psychotic disorders.
* Severe intellectual disability

Where it's running

• Necker - Enfants Malades Hospital
  Paris, Ile-de-France, France Recruiting

Study contacts

• Study coordinator: Marlène Rio, Dr
• Email: marlene.rio@aphp.fr
• Phone: 01 44 49 40 00

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions

  This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.

  Recruiting at 3 sites Istituto Giannina Gaslini · Genova and 2 other locations · NCT07893522

• Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders

  This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.

  Recruiting Istituto Giannina Gaslini · Genova · NCT07884227

• Melillo Method for kids with behavior and learning challenges

  This pilot test will see if the Melillo Method can be feasibly delivered in two Illinois schools to help kids aged 8 and up who have behavioral and learning difficulties.

  Recruiting Life University · Roodhouse, Illinois · NCT07779889

• AI-assisted Rare-Disease Diagnosis

  A multicenter randomized test to see if an AI diagnostic tool can help doctors make faster, more accurate rare-disease diagnoses for patients with unresolved symptoms.

  Recruiting at 3 sites Peking Union Medical College Hospital · Cangzhou and 11 other locations · NCT07650799

• Understanding how sensory brain signals vary in people with and without neurodevelopmental disorders

  This study tests whether people with neurodevelopmental disorders show more variation in brain responses to sensory stimulation than people without these disorders.

  Recruiting University Hospital, Tours · Tours · NCT07542977

• Socio‑professional inclusion for young people (15–25) with childhood-onset rare genetic disabilities

  This project will try to see what makes it hard for 15–25‑year‑olds with childhood-onset rare genetic conditions to access higher education, internships, or work.

  Recruiting Imagine Institute · Paris, Île-de-France Region · NCT07527624

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.